Depreciation of Kiromic Biopharma, Inc. from 30 Sep 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Kiromic Biopharma, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Sep 2019 to 31 Dec 2024.
  • Kiromic Biopharma, Inc. Depreciation for the quarter ending 31 Dec 2024 was $568,000, a 2.3% increase year-over-year.
  • Kiromic Biopharma, Inc. Depreciation for the twelve months ending 31 Dec 2024 was $2,234,000, a 0.58% increase year-over-year.
  • Kiromic Biopharma, Inc. annual Depreciation for 2024 was $2,234,000, a 0.58% increase from 2023.
  • Kiromic Biopharma, Inc. annual Depreciation for 2023 was $2,221,000, a 33% increase from 2022.
  • Kiromic Biopharma, Inc. annual Depreciation for 2022 was $1,673,400, a 256% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Kiromic Biopharma, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $2,234,000 $568,000 +$13,000 +2.3% 01 Oct 2024 31 Dec 2024 10-K 14 Feb 2025 2024 FY
Q3 2024 $2,221,000 $552,000 -$8,000 -1.4% 01 Jul 2024 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $2,229,000 $557,000 +$7,000 +1.3% 01 Apr 2024 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $2,222,000 $557,000 +$1,000 +0.18% 01 Jan 2024 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $2,221,000 $555,000 +$100 +0.02% 01 Oct 2023 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 $2,220,900 $560,000 +$23,400 +4.4% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $2,197,500 $550,000 +$150,900 +38% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $2,046,600 $556,000 +$373,200 +204% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $1,673,400 $554,900 +$416,300 +300% 01 Oct 2022 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 $1,257,100 $536,600 +$407,800 +317% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $849,300 $399,100 +$292,300 +274% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $557,000 $182,800 +$87,200 +91% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $469,800 $138,600 +$57,500 +71% 01 Oct 2021 31 Dec 2021 10-K 17 Apr 2023 2022 FY
Q3 2021 $412,300 $128,800 +$78,400 +156% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $333,900 $106,800 +$72,100 +208% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 $261,800 $95,600 +$61,800 +183% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q4 2020 $200,000 $81,100 01 Oct 2020 31 Dec 2020 10-K 08 Apr 2022 2021 FY
Q3 2020 $50,400 +$29,700 +143% 01 Jul 2020 30 Sep 2020 10-Q 11 Mar 2022 2021 Q3
Q2 2020 $34,700 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
Q1 2020 $33,800 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q3 2019 $20,700 01 Jul 2019 30 Sep 2019 10-Q 30 Nov 2020 2020 Q3

Kiromic Biopharma, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,234,000 +$13,000 +0.58% 01 Jan 2024 31 Dec 2024 10-K 14 Feb 2025 2024 FY
2023 $2,221,000 +$547,600 +33% 01 Jan 2023 31 Dec 2023 10-K 14 Feb 2025 2024 FY
2022 $1,673,400 +$1,203,600 +256% 01 Jan 2022 31 Dec 2022 10-K 19 Mar 2024 2023 FY
2021 $469,800 +$269,800 +135% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023 2022 FY
2020 $200,000 +$112,500 +129% 01 Jan 2020 31 Dec 2020 10-K 08 Apr 2022 2021 FY
2019 $87,500 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.